The program is the latest example of pharmaceutical companies bypassing traditional drug distribution channels for people who ...

Pharmaceutical giants introduce an insurance-free pathway for top anticoagulant Eliquis, following similar direct-to-patient models from Eli Lilly and Novo Nordisk.

A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly ...

On Monday, the Food and Drug Administration granted full approval for Pfizer/BioNTech’s Covid-19 vaccine, now marketed under the name Comirnaty, for everyone age 16 and up.“This is a pivotal ...

After the U.S. Food and Drug Administration gave its official stamp of approval to the Pfizer-BioNTech COVID-19 shot, some social media users tried to dismiss it by pointing to other products the ...

For its approved uses, the drug accounted for $437 million in revenue for the nine months ended Sept. 30, 2024, a 26% increase compared to the same period in the prior year, according to Pfizer ...

Alnylam Pharmaceuticals Inc. won expanded US approval for a heart drug that could be the biggest boon yet for the 23-year-old biotech — if it can beat out stiff competition from the likes of ...

The external expert committee will review data from Pfizer and German startup BioNTech on their vaccine, called BNT162b2, and by day's end will vote whether the U.S. Food and Drug Administration ...

The US Food and Drug Administration granted full approval this week for the Pfizer/BioNTech Covid-19 vaccine for people 16 years of age and older. This is the first of the coronavirus vaccines to ...

Approval for Pfizer's two-dose vaccine was originally scheduled for Labor Day but was moved up due to a ... “We expect the Food and Drug Administration to approve one or more COVID-19 vaccines ...

Pfizer-BioNTech is seeking the Food and Drug Administration's approval for its COVID-19 vaccine, with the goal of getting the agency's green light "in the coming months." ...

The US Food and Drug Administration granted full approval this week for the Pfizer/BioNTech Covid-19 vaccine for people 16 years of age and older. This is the first of the coronavirus vaccines to ...